LUCENT Appoints Simon Doyle as CEO with Matthew Goodman Taking Chief Medical Officer Position
LONDON, June 1, 2026 /PRNewswire/ -- LUCENT Biopharma Ltd. ('LUCENT') has appointed Simon Doyle (STEM, NeoHealthHub, Cencora) as CEO with immediate effect. Dr. Matthew Goodman (founder of LUCENT and outgoing CEO) will take-up the position of Chief Medical Officer, remaining a core member...
LONDON, June 1, 2026 /PRNewswire/ -- LUCENT Biopharma Ltd. ('LUCENT') has appointed Simon Doyle (STEM, NeoHealthHub, Cencora) as CEO with immediate effect. Dr. Matthew Goodman (founder of LUCENT and outgoing CEO) will take-up the position of Chief Medical Officer, remaining a core member...
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.